Literature DB >> 2194674

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides.

Y Reiss1, J L Goldstein, M C Seabra, P J Casey, M S Brown.   

Abstract

We report the identification, purification, and characterization of a farnesyl:protein transferase that transfers the farnesyl moiety from farnesyl pyrophosphate to a cysteine in p21ras proteins. The enzyme was purified approximately 60,000-fold from rat brain cytosol through use of a chromatography step based on the enzyme's ability to bind to a hexapeptide containing the consensus sequence (Cys-AAX) for farnesylation. The purified enzyme migrated on gel filtration chromatography with an apparent molecular weight of 70,000-100,000. High resolution SDS-polyacrylamide gels showed two closely spaced approximately 50 kd protein bands in the final preparation. The enzyme was inhibited competitively by peptides as short as 4 residues that contained the Cys-AAX motif. These peptides acted as alternative substrates that competed with p21H-ras for farnesylation. Effective peptides included the COOH-terminal sequences of all known p21ras proteins as well as those of lamin A and B.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194674     DOI: 10.1016/0092-8674(90)90242-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  159 in total

Review 1.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 2.  Evolving therapies: farnesyltransferase inhibitors.

Authors:  W Thomas Purcell; Ross C Donehower
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

3.  ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

Authors:  Matthew B Frankel; Brandon M Wojcik; Andrea C DeDent; Dominique M Missiakas; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

4.  RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.

Authors:  R Baron; E Fourcade; I Lajoie-Mazenc; C Allal; B Couderc; R Barbaras; G Favre; J C Faye; A Pradines
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Prenylation of mammalian Ras protein in Xenopus oocytes.

Authors:  R Kim; J Rine; S H Kim
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

6.  A tagging-via-substrate technology for detection and proteomics of farnesylated proteins.

Authors:  Yoonjung Kho; Sung Chan Kim; Chen Jiang; Deb Barma; Sung Won Kwon; Jinke Cheng; Janis Jaunbergs; Carolyn Weinbaum; Fuyuhiko Tamanoi; John Falck; Yingming Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205

Review 7.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

8.  Mutant farnesyltransferase beta subunit of Saccharomyces cerevisiae that can substitute for geranylgeranyltransferase type I beta subunit.

Authors:  H Mitsuzawa; K Esson; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Protein geranylgeranyltransferase-I of Trypanosoma cruzi.

Authors:  Kohei Yokoyama; John R Gillespie; Wesley C Van Voorhis; Frederick S Buckner; Michael H Gelb
Journal:  Mol Biochem Parasitol       Date:  2007-10-02       Impact factor: 1.759

10.  Suppression of yeast geranylgeranyl transferase I defect by alternative prenylation of two target GTPases, Rho1p and Cdc42p.

Authors:  Y Ohya; H Qadota; Y Anraku; J R Pringle; D Botstein
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.